Intervention Trial of Culturally-Appropriate Decision Aids for Smoking Cessation

NCT01566097 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2015-03-26

No results posted yet for this study

Summary

Despite the establishment of various smoking cessation methods, including pharmacological intervention, only a small proportion of smokers who visit doctors choose to receive such assistance. Such under-utilization is especially apparent in some cultures, as in the case of Korea, where a government survey showed that only 0.5% of current or formal smoker reported they had been prescribed smoking cessation medication. Shame in asking for help for an addictive disorder has been recognized as one of the most recognized cultural barrier in Asian-American population. It is clear that culturally focused studies on smoking cessation is warranted.

Patient decision aids are tools that help people become involved in decision making by providing information about the options and outcomes and by clarifying personal values. Patient decision aids have been developed to help patients decide whether to quit smoking or not, or whether to use smoking medication or not. However, such previous studies have only been focused on western populations.

The main purpose of this study is to develop a culturally appropriate decision aid for smoking cessation for the Korean population, as well as evaluate its effect on their decision to use smoking cessation medication. The investigators expect that culturally tailored smoking cessation decision aids would increase knowledge about efficacy of smoking cessation, make people have more positive attitudes toward smoking cessation medication, encourage people to discuss about smoking cessation medication with their physicians. Ultimately the investigators expect it would increase usage of smoking cessation medication and enhance the quitting rate of smoking, which is a very important clinical issue.

Conditions

  • Cigarette Smoking
  • Tobacco Use Disorder
  • Nicotine Dependence
  • Smoking Cessation

Interventions

DEVICE

Smoking Cessation Decision Aids

The decision aids were developed through: 1) literature review; 2) qualitative interviews with Korean smokers from various backgrounds; 3) expert opinions. They were in the form of short educational videos (flash), displayed by Apple's iPad. The decision aids contained the followings, in proper Korean social and cultural context: 1. Information on the risk of continued smoking and benefits of cessation 2. Messages that address common misbeliefs regarding smoking cessation services and medications 3. Information on possible smoking cessation options, their efficacy, side effects, costs, etc. The choices given in the decisions aid were: 1. Behavioral only 2. Nicotine replacement therapy 3. Bupropion 4. Varenicline

Sponsors & Collaborators

  • Pfizer

    collaborator INDUSTRY
  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Dong Wook Shin, MD,MBA,DrPH · Seoul National University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2015-02-28
Completion
2015-07-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01566097 on ClinicalTrials.gov